Anatomopathological Analysis of the Infundibulopelvic Ligament in Patients With Ovarian Cancer

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorComplejo Hospitalario Universitario Insular Materno Infantil

About this trial

Involvement of the infundibulopelvic ligament in ovarian cancer may be associated with decreased survival and related to paraaortic lymph node metastasis

Eligibility criteria

Qualifiers

◦ Patients with epithelial ovarian cancer, including high- and low-grade serous, high- and low-grade endometrioid, mucinous (expansile and infiltrative types), and carcinosarcoma.

FIGO 2014 stage IA-IVB.

Patients undergoing primary surgery or interval surgery after 3-4 or 6 cycles of chemtherapy

Patients with no residual disease after surgery.

Disqualifiers

◦ Patients without epithelial ovarian cancer.

Patients with ECOG 2-4.

Patients who do not consent to participate in the study.

Patients who did not undergo complete staging surgery (including hysterectomy, bilateral salpingo-oophorectomy, pelvic and para-aortic lymphadenectomy, and omentectomy) or with residual disease after cytoreductive surgery.

Trial design

Treatments tested in this trial

  • resection of infundibulopelvic ligament

Treatment groups

200 Participants
are divided into 1 treatment group